BioRestorative Therapies
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell BRTX and other ETFs, options, and stocks.About BRTX
BioRestorative Therapies, Inc. engages in the development of therapeutic products and medical therapies using cell and tissue protocols. Its programs provide quality of care for chronic back pain caused by disc degeneration and metabolic disorders, including obesity and diabetes.
CEOLance Alstodt
CEOLance Alstodt
Employees11
Employees11
HeadquartersMelville, New York
HeadquartersMelville, New York
Founded1997
Founded1997
Employees11
Employees11
BRTX Key Statistics
Market cap10.30M
Market cap10.30M
Price-Earnings ratio-0.78
Price-Earnings ratio-0.78
Dividend yield—
Dividend yield—
Average volume34.91K
Average volume34.91K
High today$1.23
High today$1.23
Low today$1.15
Low today$1.15
Open price$1.19
Open price$1.19
Volume46.84K
Volume46.84K
52 Week high$2.55
52 Week high$2.55
52 Week low$0.9841
52 Week low$0.9841
Stock Snapshot
As of today, BioRestorative Therapies(BRTX) shares are valued at $1.15. The company's market cap stands at 10.3M, with a P/E ratio of -0.78.
As of 2025-12-19, BioRestorative Therapies(BRTX) stock has fluctuated between $1.15 and $1.23. The current price stands at $1.15, placing the stock 0.0% above today's low and -6.5% off the high.
BioRestorative Therapies(BRTX) shares are trading with a volume of 46.84K, against a daily average of 34.91K.
During the past year, BioRestorative Therapies(BRTX) stock moved between $0.98 at its lowest and $2.55 at its peak.
During the past year, BioRestorative Therapies(BRTX) stock moved between $0.98 at its lowest and $2.55 at its peak.
People also own
Based on the portfolios of people who own BRTX. This list is generated using Robinhood data, and it’s not a recommendation.